Muneyoshi Futami
Tokyo, 1088639, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy.
Journal: Regenerative therapy
Published: August 20, 2022
The mouse homolog of the mutant WASp responsible for human X-linked neutropenia renders granulopoiesis ineffective.
Journal: Biochemical and biophysical research communications
Published: June 20, 2022
CD155 and CD112 as possible therapeutic targets of FLT3 inhibitors for acute myeloid leukemia.
Journal: Oncology letters
Published: September 21, 2021
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 06, 2020
The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells.
Journal: PloS one
Published: January 21, 2020
HDAC Inhibitors Exert Anti-Myeloma Effects through Multiple Modes of Action.
Journal: Cancers
Published: January 25, 2019
Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma.
Journal: Molecular therapy oncolytics
Published: January 25, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026